PHARMACOGENOMICS LINK RS11615 OF ERCC1 TO CISPLATIN-INDUCED OTOTOXICITY

被引:0
|
作者
Zehnhoff-Dinnesen, A. Am [1 ]
Deuster, D. [1 ]
Malath, I. [2 ]
Eveslage, M. [3 ]
Ciarimboli, G. [4 ]
Langer, T. [5 ]
Zolk, O. [6 ]
Juergens, H. [2 ]
Lanvers-Kaminsky, C. [2 ]
机构
[1] Univ Hosp Munster, Clin Phoniatr & Pedaudiol, Munster, Germany
[2] Univ Hosp Munster, Dept Pediat Hematol & Oncol, Childrens Hosp, Munster, Germany
[3] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany
[4] Univ Hosp Munster, Expt Nephrol Dept Internal Med D, Munster, Germany
[5] Univ Hosp Erlangen, Dept Hematol Oncol Cell Therapy, Hosp Children & Adolescents, Erlangen, Germany
[6] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:164 / 164
页数:1
相关论文
共 50 条
  • [1] Pharmacogenomics of cisplatin-induced ototoxicity
    Mukherjea, Debashree
    Rybak, Leonard P.
    PHARMACOGENOMICS, 2011, 12 (07) : 1039 - 1050
  • [2] ERCC1 rs11615 polymorphism increases susceptibility to breast cancer: a meta-analysis of 4547 individuals
    Li, Bingjie
    Shi, Xiaoqing
    Yuan, Yingying
    Peng, Mengle
    Jin, Huifang
    Qin, Dongchun
    BIOSCIENCE REPORTS, 2018, 38
  • [3] Association of ERCC1 rs11615 Polymorphism with the Risk of Cervical Cancer Especially in Chinese Populations: A Meta-Analysis
    Zhang, Yufeng
    Teng, Yue
    Zhu, Yuanjie
    Wu, Yi
    Wen, Yuting
    Liu, Xinjian
    Li, Dake
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [4] Association of ERCC1 Gene Polymorphisms (rs3212986 and rs11615) With the Risk of Lung Cancer in a Population From Southeast Iran
    Khalouei, Ali
    Masoumi-Ardakani, Yaser
    Jafarzaheh, Abdollah
    Khandani, Behjat Kalantari
    Sedghy, Farnaz
    Mashizi, Arezu Khosravi
    Yaghoobi, Mohammad Mehdi
    Zangouey, Mohammadreza
    Shahouzehi, Beydolah
    JOURNAL OF RESEARCH IN HEALTH SCIENCES, 2024, 24 (04)
  • [5] Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case–control studies
    Y. W. Ding
    X. Gao
    D. X. Ye
    W. Liu
    L. Wu
    H. Y. Sun
    Clinical and Translational Oncology, 2015, 17 : 710 - 719
  • [6] ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis
    Yuqiang Zhang
    Sufen Cao
    Chunyu Zhuang
    Jiacheng Chen
    Xiaojing Chen
    Hong Sun
    Shengying Lin
    Bailang Lin
    Journal of Ovarian Research, 14
  • [7] ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis
    Zhang, Yuqiang
    Cao, Sufen
    Zhuang, Chunyu
    Chen, Jiacheng
    Chen, Xiaojing
    Sun, Hong
    Lin, Shengying
    Lin, Bailang
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [8] Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studies
    Ding, Y. W.
    Gao, X.
    Ye, D. X.
    Liu, W.
    Wu, L.
    Sun, H. Y.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (09): : 710 - 719
  • [9] ERCC1 rs11615和ERCC2 rs13181基因多态性与小细胞肺癌的关联研究
    刘阿海
    王道军
    李发强
    临床肺科杂志, 2018, 23 (07) : 1213 - 1216
  • [10] Association between ERCC1 Gene Polymorphism (rs11615) and Colorectal Cancer Susceptibility: A Meta-Analysis of Medical Image Fusion and Safety Applications
    Liu, Min
    Qiu, Zhifeng
    Yang, Qi
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022